Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.
Clinical trial NCT02487498 · COMPLETED
Trial details
- NCT number
- NCT02487498
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-27
- Primary completion
- 2016-09-06
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.